Obesidad y Cáncer
OBECAN
Juan Carlos
Galofre Ferrater
Consultor Médico
Publicacions en què col·labora amb Juan Carlos Galofre Ferrater (8)
2019
-
Circulating GDF11 levels are decreased with age but are unchanged with obesity and type 2 diabetes
Aging, Vol. 11, Núm. 6, pp. 1733-1744
-
Circulating concentrations of GDF11 are positively associated with TSH levels in humans
Journal of Clinical Medicine, Vol. 8, Núm. 6
2012
-
Body mass index classification misses subjects with increased cardiometabolic risk factors related to elevated adiposity
International Journal of Obesity, Vol. 36, Núm. 2, pp. 286-294
-
Clinical usefulness of a new equation for estimating body fat
Diabetes Care, Vol. 35, Núm. 2, pp. 383-388
2011
-
Body adiposity and type 2 diabetes: Increased risk with a high body fat percentage even having a normal BMI
Obesity, Vol. 19, Núm. 7, pp. 1439-1444
2008
-
Relationship between thyroid-stimulating hormone and insulin in euthyroid obese men
Annals of Nutrition and Metabolism, Vol. 53, Núm. 3-4, pp. 188-194
2004
-
Protocolo diagnóstico de la obesidad
Medicine: Programa de Formación Médica Continuada Acreditado, Serie 9, Núm. 19, pp. 1218-1222
-
Protocolo terapéutico de los estados de desnutrición
Medicine: Programa de Formación Médica Continuada Acreditado, Serie 9, Núm. 19, pp. 1237-1239